Clinical Trial Update: Naloxegol Drug Utilization Post Authorisation Safety Study

View source ↗

Summary

A completed post-authorization safety study assessing real-world naloxegol utilization in patients with opioid-induced constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Naloxegol (naloxegol)

Snippet

Sponsor: Kyowa Kirin Pharmaceutical Development Ltd | Conditions: Opioid Induced Constipation | Status: COMPLETED